Dyssynchrony and the risk of ventricular arrhythmias

Valentina Kutyifa, Anne Catherine Pouleur, Dorit Knappe, Amin Al-Ahmad, Michal Gibinski, Paul J. Wang, Scott McNitt, Bela Merkely, Ilan Goldenberg, Scott D. Solomon, Arthur J. Moss, Wojciech Zareba

Research output: Contribution to journalArticle

52 Citations (Scopus)


Objectives: The aim of our study was to evaluate the relationship between left ventricular (LV) dyssynchrony and the risk of ventricular tachycardia (VT) or ventricular fibrillation (VF) in patients enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy) trial. Background: Intraventricular mechanical dyssynchrony might be an important factor in ventricular arrhythmogenesis by enhancing electrical heterogeneity in heart failure patients. The effects of dyssynchrony have not yet been evaluated in a large cohort of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy with defibrillator (CRT-D) patients. Methods: LV dyssynchrony was measured at baseline and at 12-months by speckle-tracking echocardiography, defined as the standard deviation of time to peak systolic strain in 12 LV myocardial segments. The endpoint was the first VT/VF/death or VT/VF. LV dyssynchrony was evaluated in 764 left bundle branch block (LBBB) patients and in 312 non-LBBB patients. Results: Baseline LV dyssynchrony was not predictive of VT/VF/death or VT/VF in LBBB or non-LBBB patients in either treatment arm. In CRT-D patients with LBBB, improvement in LV dyssynchrony over a year was associated with significantly lower incidence of VT/VF/death (p < 0.001) and VT/VF (p < 0.001) compared to ICD patients and to CRT-D patients with unchanged or worsening dyssynchrony. Among LBBB patients, 15% decrease in LV dyssynchrony was associated with lower risk of VT/VF/death (hazard ratio: 0.49, 95% confidence interval: 0.24 to 0.99, p = 0.049) and VT/VF (hazard ratio: 0.30, 95% confidence interval: 0.12 to 0.77, p = 0.009) as compared to ICD patients. Patients without LBBB receiving CRT-D did not show reduction in VT/VF/death or in VT/VF in relation to improving dyssynchrony when evaluating cumulative event rates or risk of events. Conclusions: Baseline LV dyssynchrony did not predict VT/VF/death or VT/VF in mild heart failure patients with or without LBBB. CRT-induced improvement of LV dyssynchrony was associated with significant reduction of ventricular arrhythmias in patients with LBBB. (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]; NCT00180271)

Original languageEnglish
Pages (from-to)432-444
Number of pages13
JournalJACC: Cardiovascular Imaging
Issue number4
Publication statusPublished - Apr 2013


  • cardiac resynchronization therapy
  • heart failure
  • implantable cardioverter-defibrillator
  • ventricular arrhythmia
  • ventricular dyssynchrony

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Dyssynchrony and the risk of ventricular arrhythmias'. Together they form a unique fingerprint.

  • Cite this

    Kutyifa, V., Pouleur, A. C., Knappe, D., Al-Ahmad, A., Gibinski, M., Wang, P. J., McNitt, S., Merkely, B., Goldenberg, I., Solomon, S. D., Moss, A. J., & Zareba, W. (2013). Dyssynchrony and the risk of ventricular arrhythmias. JACC: Cardiovascular Imaging, 6(4), 432-444. https://doi.org/10.1016/j.jcmg.2012.12.008